Peter Vandenberghe

26.1k citations
324 papers · 20.8k · 6 hit papers · h-index 71

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 60
    • Chronic Myeloid Leukemia Treatments 55
    • Chronic Lymphocytic Leukemia Research 54

Peter Vandenberghe

311 papers receiving 20.1k citations

Peter Vandenberghe's Hit Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma 2021 · 1.1k citations
1.1k0+7+15Years since publication50010001.5k2.0k2.5k

Peers

Peter Vandenberghe
Comparison fields: 5 of 142
  • Hematology 6.1k
  • Genetics 5.2k
  • Rheumatology 3.2k
  • Pathology and Forensic Medicine 3.6k
  • Immunology 3.7k
Replace Gregor E. G. Verhoef with:
Gregor E. G. Verhoef Belgium
Daniel A. Arber United States
Lothar Kanz Germany
Attilio Orazi United States
Robert Paul Hasserjian United States
Jiri Mayer Czechia
Brigitte Schlegelberger Germany
Oliver Gerhard Ottmann Germany
Jeffrey Tyner United States
Katherine R. Calvo United States
Peter Vandenberghe relative to Gregor E. G. Verhoef Belgium Gregor E. G. Verhoef's profile →
Citations per field
00.5×1.5×2×2.3×
Gregor E. G. Verhoef · 1×
Citations per year

Countries citing papers authored by Peter Vandenberghe

Since Specialization
Citations

This map shows the geographic impact of Peter Vandenberghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vandenberghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vandenberghe more than expected).

Fields of papers citing papers by Peter Vandenberghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vandenberghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vandenberghe. The network helps show where Peter Vandenberghe may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Vandenberghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Vandenberghe Line = papers co-authored together Peter Vandenberghe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Hit paper breakdown →
20052544
2
A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Hit paper breakdown →
20031347
3
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Hit paper breakdown →
20211148
4
Acquired mutations in TET2 are common in myelodysplastic syndromes
Hit paper breakdown →
2009647
5
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Hit paper breakdown →
2010637
6
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Hit paper breakdown →
2012534
7 2001387
8 2001348
9 2002347
10 2012347
11 2004339
12 1999324
13 2014230
14 2007228
15 2011227
16 1996216
17 2006212
18 2010209
19 2020198
20 2003190

About Peter Vandenberghe

Peter Vandenberghe is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Oncology, having authored 324 papers that have together received 20.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (71 papers), Acute Myeloid Leukemia Research (60 papers), Chronic Myeloid Leukemia Treatments (55 papers), Chronic Lymphocytic Leukemia Research (54 papers), Immune Cell Function and Interaction (40 papers), Acute Lymphoblastic Leukemia research (36 papers), Eosinophilic Disorders and Syndromes (32 papers) and T-cell and B-cell Immunology (30 papers). The work is most often cited by research in Hematology (6.1k citations), Genetics (5.2k citations), Rheumatology (3.2k citations), Pathology and Forensic Medicine (3.6k citations) and Immunology (3.7k citations). Peter Vandenberghe has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Jan Ceuppens, Gregor E. G. Verhoef, Jan Cools, Iwona Włodarska, Sigrid G. Stroobants, Lucienne Michaux, José Thomas, Karoline Spaepen, Peter Marynen and Patrick J. Dupont. Their work appears in journals such as Blood, Leukemia, Haematologica, British Journal of Haematology and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact